newsfilter
← Latest News
Business Wire·

Humanigen Announces Participation and Presentation at Multiple Conferences in June

Humanigen, Inc. (NASDAQ:HGEN) ("Humanigen"), a late-stage clinical biopharmaceutical company focused on preventing and treating an immune hyper-response called ‘cytokine storm' announced today that representatives will present and participate at multi